BIOHEART-B(02185),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02185 BIOHEART-B

Market Closed 04-17 16:08:09

2.140

-0.040

-1.83%

High2.180	Low2.050	Vol97.10K
Open2.180	D1 Closing2.180	Amplitude5.96%
Mkt Cap522.03M	Tradable Cap505.04M	Total Shares243.94M
T/O205.63K	T/O Rate0.04%	Tradable Shares236.00M
P/B0.74	ROE-12.83%	EPS-0.38
52wk High3.670	52wk Low1.260	P/E-5.57
Dividend0.00	Div.Yield0.00	ROA-4.92%

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"02185","market":"HK","secType":"STK","nameCN":"BIOHEART-B","latestPrice":2.14,"timestamp":1744877289030,"preClose":2.18,"halted":0,"volume":97100,"delay":0,"floatShares":236000000,"shares":243937000,"eps":-0.384131994681966,"marketStatus":"Market Closed","change":-0.04,"latestTime":"04-17 16:08:09","open":2.18,"high":2.18,"low":2.05,"amount":205631,"amplitude":0.059633,"askPrice":2.19,"askSize":15000,"bidPrice":2.14,"bidSize":19700,"shortable":0,"etf":0,"ttmEps":-0.384131994681966,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1640188800000,"exchange":"SEHK","adjPreClose":2.18,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":3.53862974405727,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02185","defaultTab":"news","newsList":[{"id":"2522550675","title":"Shanghai Bio-Heart Biological Technology FY EPS RMB -0.36","url":"https://stock-news.laohu8.com/highlight/detail?id=2522550675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522550675?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 22:47","pubTimestamp":1743173227,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nPLX1009C4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","02185"],"gpt_icon":0},{"id":"2514833137","title":"Shanghai Bio-heart Biological Technology Gets China Nod for Catheter System","url":"https://stock-news.laohu8.com/highlight/detail?id=2514833137","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514833137?lang=en_us&edition=full_marsco","pubTime":"2025-02-26 19:14","pubTimestamp":1740568457,"startTime":"0","endTime":"0","summary":"Shanghai Bio-heart Biological Technology  obtained approval for Iberis Multi-Electrode Renal Artery Radiofrequency Ablation Catheter System from China's National Medical Products Administration for the treatment of hypertension patients, a Wednesday filing with the Hong Kong bourse said.The system has been developed by unit Shanghai AngioCare Medical Technology, according to the interventional cardiovascular device company.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02185","BK1100"],"gpt_icon":0},{"id":"2514864878","title":"Shanghai Bio-Heart Biological Technology Co Ltd -  Nmpa Approval for Registration of Iberis Rdn System","url":"https://stock-news.laohu8.com/highlight/detail?id=2514864878","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514864878?lang=en_us&edition=full_marsco","pubTime":"2025-02-26 17:03","pubTimestamp":1740560617,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02185","BK1100"],"gpt_icon":0},{"id":"2505837018","title":"Shanghai Bio-heart Shareholders to Vote Feb. 13 on Capital Injection for Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2505837018","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505837018?lang=en_us&edition=full_marsco","pubTime":"2025-01-24 14:31","pubTimestamp":1737700302,"startTime":"0","endTime":"0","summary":"Shareholders of Shanghai Bio-heart Biological Technology  will meet Feb. 13 to vote on the proposed 155.6 million yuan capital injection into unit Zhejiang Bioheart Medical Equipment, a Thursday bourse filing said.The parties had agreed on earlier in January that Jiaxing Guojian Baixin Equity Investment Partnership Enterprise would make the investment in exchange for a 45.3208% stake in Zhejiang Bioheart.Price : $1.55, Change: $+0.010, Percent Change: +0.65%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HKD","BK4588","BK4526","BK4023","BK4585","BK1100","02185"],"gpt_icon":0},{"id":"2503373639","title":"Shanghai Bio-heart Delays Dispatch of Circular for Stake Sale in Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2503373639","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503373639?lang=en_us&edition=full_marsco","pubTime":"2025-01-13 17:24","pubTimestamp":1736760273,"startTime":"0","endTime":"0","summary":"Shanghai Bio-heart Biological Technology  delayed the dispatch of a circular regarding the disposal of a 45.3% stake in Zhejiang Bioheart Medical Equipment to Jan. 27, a Friday Hong Kong bourse filing said.The interventional cardiovascular device company needs additional time to finalize certain information to be included in the circular.The firm is selling the stake to Jiaxing Guojian Baixin Equity Investment Partnership Enterprise in exchange for a 155.6 million yuan capital injection in the unit, according to a Jan. 2 disclosure.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1100","02185"],"gpt_icon":0},{"id":"2500961286","title":"Shanghai Bio-heart Subsidiary Receives 155.6 Million Yuan Capital Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2500961286","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500961286?lang=en_us&edition=full_marsco","pubTime":"2025-01-02 10:15","pubTimestamp":1735784124,"startTime":"0","endTime":"0","summary":"Shanghai Bio-heart Biological Technology  subsidiary Zhejiang Bioheart Medical Equipment will receive a 155.6 million yuan capital injection from Jiaxing Guojian Baixin Equity Investment Partnership Enterprise in exchange for a 45.3208% stake in Zhejiang Bioheart.Upon completion of the capital increase, Shanghai Bio-heart's stake in Zhejiang Bioheart will be reduced to 54.6792%, with Jiaxing Guojian Baixin Equity Investment Partnership Enterprise holding the remainder.Price : $1.64, Change: $-0.050, Percent Change: -2.96%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1100","BK4526","BK4023","02185","BK4585","BK4588","HKD"],"gpt_icon":0},{"id":"2500963346","title":"BRIEF-Shanghai Bio-Heart Biological Technology Says Investor To Inject RMB155.6 Mln In Zhejiang Bioheart","url":"https://stock-news.laohu8.com/highlight/detail?id=2500963346","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500963346?lang=en_us&edition=full_marsco","pubTime":"2025-01-02 08:57","pubTimestamp":1735779465,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Bio-Heart Biological Technology Says Investor To Inject RMB155.6 Mln In Zhejiang BioheartJan 2  - Shanghai Bio-heart Biological Technology Co Ltd 2185.HK:INVESTOR AGREED TO INJECT RMB155.6 MILLION INTO ZHEJIANG BIOHEARTFurther company coverage: 2185.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250102:nFWN3NW01K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02185"],"gpt_icon":0},{"id":"2500523539","title":"Shanghai Bio-Heart Biological Technology - Investor Agreed to Inject RMB155.6 Mln Into Zhejiang Bioheart","url":"https://stock-news.laohu8.com/highlight/detail?id=2500523539","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500523539?lang=en_us&edition=full_marsco","pubTime":"2025-01-02 07:32","pubTimestamp":1735774336,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250101:nFWN3NW01K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","02185"],"gpt_icon":0},{"id":"2489234104","title":"BRIEF-Shanghai Bio-Heart Biological Technology Announces Formation Of Limited Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2489234104","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489234104?lang=en_us&edition=full_marsco","pubTime":"2024-12-06 23:21","pubTimestamp":1733498507,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Bio-Heart Biological Technology Announces Formation Of Limited PartnershipDec 6  - Shanghai Bio-heart Biological Technology Co Ltd 2185.HK:FORMATION OF LIMITED PARTNERSHIPNANJING GUOJIAN JINQUAN EQUITY INVESTMENT MANAGEMENT, OTHERS ENTER LIMITED PARTNERSHIP AGREEMENTFurther company coverage: 2185.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nFWN3N70DR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02185","BK1100"],"gpt_icon":0},{"id":"2489331239","title":"Shanghai Bio-Heart Biological Technology - Nanjing Guojian Jinquan Equity Investment Management, Others Enter Limited Partnership Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2489331239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489331239?lang=en_us&edition=full_marsco","pubTime":"2024-12-06 22:43","pubTimestamp":1733496210,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nFWN3N70DR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02185","BK1100"],"gpt_icon":0},{"id":"2483556541","title":"We Think Shanghai Bio-heart Biological Technology (HKG:2185) Can Afford To Drive Business Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2483556541","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483556541?lang=en_us&edition=full_marsco","pubTime":"2024-11-16 07:24","pubTimestamp":1731713077,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2185/shanghai-bio-heart-biological-technology-shares/news/we-think-shanghai-bio-heart-biological-technology-hkg2185-ca-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1100","02185"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bio-heart.com","stockEarnings":[{"period":"1week","weight":0.07},{"period":"1month","weight":-0.3206},{"period":"3month","weight":0.4267},{"period":"6month","weight":0.2022},{"period":"1year","weight":0.0594},{"period":"ytd","weight":0.3049}],"compareEarnings":[{"period":"1week","weight":0.0345},{"period":"1month","weight":-0.1352},{"period":"3month","weight":0.0925},{"period":"6month","weight":0.0284},{"period":"1year","weight":0.3165},{"period":"ytd","weight":0.0666}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Shanghai Bio-heart Biological Technology Co Ltd is a China-based company mainly engaged in the business of interventional instruments. The Company's main businesses are the development and production of interventional cardiovascular devices. The Company's main products include fully bioresorbable scaffolds (BRS) and renal denervation (RDN). The Company's products are mainly used to meet medical needs for the treatment of coronary, peripheral artery disease and hypertension. The Company's products are used in addressing the unmet medical needs of Chinese patients for the treatment of coronary artery diseases and the unmet medical needs of patients for the treatment of uncontrolled hypertension. The Company mainly conducts its businesses in the domestic market and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.037442},{"month":2,"riseRate":0.25,"avgChangeRate":0.033464},{"month":3,"riseRate":0.5,"avgChangeRate":0.056757},{"month":4,"riseRate":0.5,"avgChangeRate":0.094405},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.068388},{"month":6,"riseRate":0.666667,"avgChangeRate":0.031003},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.045373},{"month":8,"riseRate":0,"avgChangeRate":-0.109703},{"month":9,"riseRate":0.333333,"avgChangeRate":0.003951},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.034879},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.14896},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.262174}],"exchange":"SEHK","name":"BIOHEART-B","nameEN":"BIOHEART-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BIOHEART-B(02185),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BIOHEART-B(02185) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BIOHEART-B,02185,BIOHEART-B股票,BIOHEART-B股票老虎,BIOHEART-B股票老虎国际,BIOHEART-B行情,BIOHEART-B股票行情,BIOHEART-B股价,BIOHEART-B股市,BIOHEART-B股票价格,BIOHEART-B股票交易,BIOHEART-B股票购买,BIOHEART-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BIOHEART-B(02185),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BIOHEART-B(02185) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}